INMD vs. GMED
INMD (InMode Ltd.) and GMED (Globus Medical, Inc.) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, INMD returned -22.05%/yr vs 0.14%/yr for GMED. At a 0.35 correlation, their price movements are largely independent.
Performance
INMD vs. GMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INMD achieves a 3.13% return, which is significantly higher than GMED's -8.66% return.
INMD
- 1D
- -0.85%
- 1M
- 12.64%
- 6M
- 4.55%
- YTD
- 3.13%
- 1Y
- 2.99%
- 3Y*
- -30.40%
- 5Y*
- -22.05%
- 10Y*
- —
GMED
- 1D
- 2.10%
- 1M
- -0.80%
- 6M
- -13.05%
- YTD
- -8.66%
- 1Y
- 39.62%
- 3Y*
- 8.78%
- 5Y*
- 0.14%
- 10Y*
- 12.40%
INMD vs. GMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
INMD InMode Ltd. | 3.13% | -12.04% | -24.91% | -37.70% | -49.42% | 197.30% | 21.12% | 187.71% |
GMED Globus Medical, Inc. | -8.66% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 21.10% |
Correlation
The correlation between INMD and GMED is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Aug 8, 2019 | 0.35 |
Fundamentals
INMD:
$870.83M
GMED:
$10.76B
INMD:
$1.36
GMED:
$4.28
INMD:
11.11
GMED:
18.61
INMD:
2.59
GMED:
3.52
INMD:
1.46
GMED:
2.33
INMD:
$374.64M
GMED:
$3.10B
INMD:
$291.61M
GMED:
$1.58B
INMD:
$98.61M
GMED:
$803.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INMD vs. GMED — Risk / Return Rank
INMD
GMED
INMD vs. GMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for InMode Ltd. (INMD) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INMD | GMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.72 | ||
| Sortino ratioReturn per unit of downside risk | -1.50 | ||
| Omega ratioGain probability vs. loss probability | 1.05 | 1.22 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 0.13 | 1.80 | -1.67 |
| Martin ratioReturn relative to average drawdown | 0.25 | 4.33 | -4.08 |
Loading charts...
Drawdowns
INMD vs. GMED - Drawdown Comparison
The maximum INMD drawdown since its inception was -86.96%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for INMD and GMED.
Loading charts...
Drawdown Indicators
| INMD | GMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.96% | -47.91% | -39.05% |
Max Drawdown (1Y)Largest decline over 1 year | -23.23% | -22.10% | -1.13% |
Max Drawdown (3Y)Largest decline over 3 years | -72.28% | -44.40% | -27.88% |
Max Drawdown (5Y)Largest decline over 5 years | -86.96% | -47.91% | -39.05% |
Max Drawdown (10Y)Largest decline over 10 years | — | -47.91% | — |
Current DrawdownCurrent decline from peak | -84.52% | -17.63% | -66.89% |
Average DrawdownAverage peak-to-trough decline | -56.37% | -15.33% | -41.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.85% | 9.18% | +2.67% |
Volatility
INMD vs. GMED - Volatility Comparison
The current volatility for InMode Ltd. (INMD) is 11.57%, while Globus Medical, Inc. (GMED) has a volatility of 13.75%. This indicates that INMD experiences smaller price fluctuations and is considered to be less risky than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INMD | GMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.57% | 13.75% | -2.18% |
Volatility (6M)Calculated over the trailing 6-month period | 25.76% | 25.02% | +0.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 34.06% | 49.57% | -15.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 52.06% | 38.29% | +13.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.66% | 35.70% | +24.96% |
Dividends
INMD vs. GMED - Dividend Comparison
Neither INMD nor GMED has paid dividends to shareholders.
Financials
INMD vs. GMED - Financials Comparison
This section allows you to compare key financial metrics between InMode Ltd. and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
INMD vs. GMED - Profitability Comparison
INMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, InMode Ltd. reported a gross profit of 61.55M and revenue of 82.02M. Therefore, the gross margin over that period was 75.1%.
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
INMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, InMode Ltd. reported an operating income of 10.06M and revenue of 82.02M, resulting in an operating margin of 12.3%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
INMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, InMode Ltd. reported a net income of 11.56M and revenue of 82.02M, resulting in a net margin of 14.1%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
Frequently Asked Questions
INMD and GMED have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMED has higher volatility (13.75%) compared to INMD (11.57%). In terms of maximum drawdown, INMD dropped -86.96% vs GMED's -47.91%.
GMED currently has the higher Sharpe Ratio (0.80 vs 0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INMD and GMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer